169329 ⎘
Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
Method for obtaning thin fibril collagen by contacting native collagen with an antibody
#602DIFFERENTIATION OF CAUSES OF RIGHT HEART FAILURE
#603Method for Identifying and Selecting Cardiomyocytes
#604JOINT DESTRUCTION BIOMARKERS FOR ANTI-IL-17A THERAPY OF INFLAMMATORY JOINT DISEASE
#605MARKER SPECIFIC TO AN OXIDATIVE DEGRADATION OF TISSUES CONTAINING TYPE III COLLAGEN, MEANS AND METHODS AND KITS FOR THE DIAGNOSIS, MONITORING OR PROGNOSIS OF PATHOLOGIES TARGETED BY THIS MARKER
#606Methods of using gelsolin levels to characterize a subject's risk of developing rheumatoid arthritis
#607DIAGNOSTIC METHOD AND PROGNOSTIC TOOL FOR OSTEOARTHRITIS
#608Monoclonal antibodies for cartillage oligomeric matrix protein
#609Immunoassay for quantification of an unstable antigen selected from BNP and proBNP
#610COMPOSITIONS AND METHODS RELATED TO PROTEIN DISPLACEMENT THERAPY FOR MYOTONIC DISTROPHY
#611Released cytokeratins as markers for epithelial cells
#612Making a prognosis in cases of cardiac disease using a combination of markers
#613Diagnosis and Prevention of Fetal Heart Disease
#614Conditional Mst overexpressing construct and conditional myostatin overexpressing transgenic mouse
#615NOVEL METHODS FOR THE ASSAY OF TROPONIN I AND T AND COMPLEXES OF TROPONIN I AND T AND SELECTION OF ANTIBODIES FOR USE IN IMMUNOASSAYS
#616Method and device for immunoassay using nucleotide conjugates
#617Thrombospondin fragments and binding agents in the detection, diagnosis and evaluation of cancer
#618METHODS FOR EVALUATING OSTEOARTHRITIS RISK
#619MATRIX MARKER MODEL AND METHODS FOR ASSESSING AND TREATING ARTHRITIS AND RELATED DISORDERS
#620Biglycan and related therapeutics and methods of use
#621METHODS OF DIAGNOSING MUSCLE DAMAGE
#622Blood biomarkers for bone fracture and cartilage injury
#623COMPOSITIONS AND METHODS FOR DETECTING AND TREATING ENDOTHELIAL DYSFUNCTION
#624PROCESS FOR NORMALIZING THE CONCENTRATION OF ANALYTES IN A URINE SAMPLE
#625Kits for biomarker detection and treatment selection
#626Compositions and methods for treating and diagnosing cancer
#627Prevention of tissue ischemia, related methods and compositions
#628METHOD AND MEANS FOR TREATMENT OF OSTEOARTHRITIS
#629CRTAC AS A BIOMARKER, THERAPEUTIC AND DIAGNOSTIC TARGET
#630Diagnostic means and methods using troponin T and NT-proBNP
#631Sclerostin and the inhibition of Wnt signaling and bone formation
#632Methods for Detecting Overexpression of SPARC and Therapeutic and Diagnostic Methods Relating to Same
#633Methods for Reducing Sample Size of Clinical Trials
#634Inhibition of SOX9 function in the treatment of proteoglycan-associated pathophysiological conditions
#635Methods of treating smooth muscle cell disorders
#636Method for Identifying an Agent that Modulates Arginine Transport in a Chondrocyte
#637Methods of using F-spondin as a biomarker for cartilage degenerative conditions and bone diseases
#638Diagnostic marker for diabetic vascular complications
#639Methods for early diagnosis of acute coronary syndrome
#640Diagnostic test for cardiomyopathy
#641Detection or Quantification of Aggrecan and its Fragments
#642METHODS OF DIAGNOSIS AND PROGNOSIS FOR A MUSCULAR DYSTROPHY
#643Novel Monoclonal Anitbody and Use thereof
#644Methods of diagnosing acute cardiac disorders using BNP-SP
#645METHOD AND COMPOSITIONS FOR HIGHLY SENSITIVE DETECTION OF MOLECULES
#646System and assay for detection of cardiac markers for assessing acute myocardial infarction
#647AGENTS AND METHODS FOR DIAGNOSING OSTEOARTHRITIS
#648Specific binding sites in collagen for integrins and use thereof
#649Gene and Cognate Protein Profiles and Methods to Determine Connective Tissue Markers in Normal and Pathologic Conditions
#650Detection of specific nitrated markers
#651Methods for treating fibrosis using CRP antagonists
#652Methods for diagnosis of cardiovascular disease
#653BMP-1 procollagen c-proteinase for diagnosis and treatment of bone and soft tissue defects and disorders
#654DIAGNOSTIC BIOMARKERS FOR VASCULAR ANEURYSM
#655Type IV collagen-like immunoreactive peptide
#656Peptide for inhibition of calcineurin, nucleic acid, antibody, and diagnostic and therapeutic methods of use
#657Molecular targets and compounds, and methods to identify the same, useful in the treatment of joint degenerative and inflammatory diseases
#658DNA encoding polypeptide capable of modulating muscle-specific tyrosine kinase activity
#659METHODS OF DIAGNOSING MUSCLE DAMAGE
#660Method for quantitation of collagen in tissue
#661Screening method for bone morphogenetic mimetics
#662Molecular targets and compounds, and methods to identify the same, useful in the treatment of bone and joint degenerative diseases
#663Muscle lamin A/C interacting protein, gene encoding same, and uses therefor
#664Method of Correlating Marker Molecule Concentration To A Specific Cell Potency Level in Chondrocyte Culture
#665Method for diagnosing cardiovascular diseases
#666Differentiation of acute and chronic myocardial necrosis in symptomatic patients
#667ActRIIB Fusion Polypeptides and Uses Therefor
#668Methods and compositions relating to HDAC 4 and 5 regulation of cardiac gene expression
#669ActRIIB Fusion Polypeptides and Uses Therefor
#670Modulation of exon recognition in pre-mRNA by interfering with the secondary RNA structure
#671Method of treating fibrosis in a subject in need thereof comprising administering a composition comprising a CSD
#672Methods of diagnosing osteoarthritis
#673Methods for identification, and compounds useful for the treatment of degenerative and inflammatory diseases
#674Methods and Compositions for Measuring Canine BNP and Uses Thereof
#675Use of glycosaminoglycans to reduce non-specific binding in immunoassays
#676CONNEXIN 40 TISSUE SPECIFIC GENE MUTATIONS
#677NT-proANP and NT-proBNP for diagnosing cardiac diseases
#678Method for monitoring collagen type II degradation in cartilage
#679Genetically encoded bioindicators of calcium-ions
#680Cardiac hormones for assessing cardiovascular risk
#681High throughput sarcomeric assay
#682Molecules for the treatment of lung disease involving an immune reaction to connective tissue found in the lung
#683Polynucleotides and polypeptide sequences involved in the process of bone remodeling
#684Antibodies and molecules derived therefrom that bind to STEAP-1 proteins
#685Method for increasing body height comprising systemic administration of CNP-53
#686Differential Immunoassay
#687ASSAY FOR CARDIAC TROPONIN AUTOANTIBODIES
#688Compositions And Methods For Stem Cell Expansion
#689METHODS AND TOOLS FOR DETECTING COLLAGEN DEGRADATION
#690Methods For Measuring Bone Formation
#691Reducing or avoiding muscle cramps
#692Reducing or avoiding muscle cramps
#693Biglycan and related therapeutics and methods of use
#694Use of Serum/Glucocorticoid-Regulated Kinase
#695NELL-1 enhanced bone mineralization
#696Highly Sensitive System and Methods for Analysis of Troponin
#697Novel bone mineralization protein expression systems, and methods of studying their intracellular signaling pathways
#698Methods of evaluating cells and cell cultures
#699Peptide for differentiating osteoarthritis from rheumatoid arthritis and non-disease conditions
#700Methods for treatment with bucindolol based on genetic targeting
#701Method for screening therapeutic agents for disuse muscular atrophy using interaction between selected proteins and a polyubiquitin chain
#702Monitoring of Cardiac Natriuretic Peptides During Diagnosis, Management, and Treatment of Cardiac Diseases
#703Diagnosis of collagen IX destruction
#704Method for identifying a subject at risk of developing heart failure by determining the level of galectin-3 or thrombospondin-2
#705Cardiovascular safety assay
#706METHODS AND MEANS FOR INFLUENCING INTERCELLULAR COMMUNICATION AND INTERCELLULAR ORGANELLE TRANSPORT
#707NATRIURETIC PEPTIDE RATIO FOR DIAGNOSING CARDIAC DYSFUNCTIONS
#708BREATH TEST
#709Immunoassay
#710Reducing or avoiding muscle cramps
#711Human G protein-coupled receptor and modulators thereof for the treatment of cell death-related disorders
#712Actin proteins as biomarkers for indication and targeting of resistance and sensitivity to an Abl kinase inhibitor in patients with chronic myelogenous leukemia
#713Methods for treatment with bucindolol based on genetic targeting
#714Method For The In Vitro Diagnosis Of The Exclusion Of Acute Coronary Syndromes
#715ActRIIB Fusion Polypeptides and Uses Therefor
#716Bone mineralization protein expression systems, and methods of studying intracellular signaling pathways induced thereby
#717Gene expression control DNA element and associated protein
#718Method for quantitation of collagen in tissue
#719Method for isolating and/or identifying mesenchymal stem cells (MSC)
#720Antibodies Against an Extracellular Matrix Complex and Their Use in the Detection of Cancer
#721Antibody specific for a chondroitin sulphate epitope
#722Use of Modulators of a Novel Form of Muscle Selective Calcineurin Interacting Protein (Mcip-1-38) as a Treatment for Cardiovascular Diseases
#723Cellular fibronectin as a diagnostic marker in cardiovascular disease and methods of use thereof
#724High Throughput Collagen Synthesis Assay
#725Method of detemining tropomyosin in chitosan
#726Uncoupled collagen synthesis and degradation assays
#727Cardiac muscle function and manipulation
#728High throughput sarcomeric assay
#729Monitoring of Vitamin K Nutritional Status
#730ASSAYS AND PEPTIDE SUBSTRATE FOR DETERMINING AGGRECAN DEGRADING METALLO PROTEASE ACTIVITY
#731Methods for evaluating osteoarthritis risk
#732Reduction of platelet interference in plasma assay samples
#733Methods of reducing skin damage and edema
#734Prognostic Methods for Congestive Heart Failure
#735Method of diagnosing osteoarthritis
#736Methods for improving the recovery of troponin I and T in membranes, filters and vessels
#737Methods and compositions for treating disorders of the extracellular matrix
#738Anti-myostatin antibodies
#739Native analyte as a reference in lateral flow assays
#740Methods and compositions for determining the efficacy of a treatment for ankylosing spondylitis using biomarkers
#741Measuring troponin antibodies to assess cardiovascular risk
#742Immunoassay and kit for an early and simultaneous detection of biochemical markers in a patient's sample
#743Sandwich immunoassay and monoclonal antibodies for COMP, Cartillage Oligomeric Matrix Protein
#744Anti-CCPand antinuclear antibodies in diagnosis of rheumatoid arthritis
#745SCLERAXIS
#746Cardiac muscle function and manipulation
#747Reagents and method for modulating Dkk-mediated interactions
#748Methods of detecting lubricin
#749Treatment of infections utilizing antibodies that bind to fibronectin binding proteins
#750Diagnosis and prevention of fetal heart disease
#751Compositions and methods for treating and diagnosing cancer
#752Use of modified extracellular matrix proteins in diagnosis and treatment of atherosclerosis
#753ASSAYS FOR NEUTRALIZING ANTIBODIES
#754Specific binding sites in collagen for integrins and use thereof
#755Stabilization of cardiac troponin
#756Method and apparatus for measuring cartilage condition biomarkers
#757Characterization of microbial deposition and immune response at the basement membrane and methods relating thereto
#758Method of identifying N-terminal proBNP
#759Compositions and methods for modulating connexin hemichannels
#760Method for detecting cardiac ischemia via changes in b-natriuretic peptide levels
#761Methods and compositions for diagnosing and treating arthritic disorders and regulating bone mass
#762Immunoassay device for diagnosing congestive heart failure and predicting mortality in congestive heart failure patients
#763Methods of assaying connective tissue growth factor
#764Whole cell assay for inhibitors of cathepsin k
#765Method and means for treatment of osteoarthritis
#766Modulation of osteoblast activity by fhl2
#767Monoclonal antibody reagents
#768Methods and compositions related to joint inflammation diseases
#769Method of modulating smooth muscle cell functioning by modulating sphingosine kinase mediated signalling
#770Thrombospondin fragments and uses thereof in clinical assays for cancer and generation of antibdies and other binding agents
#771Serum biomarkers in ischaemic heart disease
#772Diagnosis of acute myocardial, ischemic diseases
#773Cardiac hormones for assessing cardiovascular risk
#774Polyclonal-polyclonal ELISA assay for detecting N-terminus-proBNP
#775Cardiac muscle function and manipulation
#776Compositions and methods for bone formation and remodeling
#777Cardiac muscle function and manipulation
#778Electrochemical detection of ischemia
#779Methods for treatment with bucindolol based on genetic targeting
#780Method for analyzing tumor aggressivity comprising measurement of polymerized actin
#781Model of bone disease amenable to high-throughput screening
#782Homing peptides to receptors of heart vasculature
#783Modulation of exon recognition in pre-mRNA by interfering with the secondary RNA structure
#784Novel gene overexpressed in heart and skeletal muscle and use thereof
#785Distinction method for the catch capacity of proteins
#786Tissue sensor and uses thereof
#787Modulation of exon recognition in pre-mRNA by interfering with the secondary RNA structure
#788Molecular targets and compounds, and methods to identify the same, useful in the treatment of joint degenerative and inflammatory diseases
#789Endocan compositions and methods for the treatment of neoplasms
#790Elastin prevents occlusion of body vessels by vascular smooth muscle cells
#791Methods for diagnosis and prognosis of cancer
#792Methods and compositions for monitoring cell migration and identifying clinically relevant cytotoxic T lymphocyte activity
#793Diagnostic markers of acute coronary syndrome and methods of use thereof
#794Diagnostic marker
#795Diagnostic marker
#796Methods and compositions for measuring canine BNP and uses thereof
#797Methods of treating smooth muscle cell disorders
#798Indirect detection of cardiac markers for assessing acute myocardial infarction
#799Prognostic tests for development of dermal stretch marks and implications for the preventive treatment thereof
#800Methods and composition for modulating type I muscle formation using pgc-1 alpha
#801Sclerostin and the inhibition of WNT signaling and bone formation
#802Methods and kits for separation and detection of proteins in biological samples
#803Detection of oncofetal fibronectin for selection of concepti
#804Oncofetal fibronectin as a marker for pregnancy-related indications
#805Oncofetal fibronectin as a marker for health and disease
#806Methods for detecting oncofetal fibronectin
#807Samples for detection of oncofetal fibronectin and uses thereof
#808Molecular flux rates through critical pathways measured by stable isotope labeling in vivo, as biomarkers of drug action and disease activity
#809Methods and compositions to promote bone homestasis
#810In vitro wound healing assay and device
#811Point of care diagnostic systems
#812Methods and compositions to promote bone homeostasis
#813Methods for identification, and compounds useful for the treatment of degenerative & inflammatory diseases
#814Point of care diagnostic systems
#815Method of determining time of death
#816Methods and agents for maintaining muscle mass and for preventing muscle atrophy and biomarkers for monitoring same
#817High throughput actin polymerization assay
#818Polyclonal-polyclonal ELISA assay for detecting N-terminus-proBNP
#819Biomarkers for wound healing
#820Methods for treating congestive heart failure
#821Method of assessing the risk of atherosclerosis
#822Differential immunoassay
#823Method for monitoring treatment with a parathyroid hormone
#824Chromatin remodeling protein as a marker expressed by stromal progenitor cells
#825Methods and tools for detecting collagen degradation
#826Breath test
#827Methods for determining levels of human b-type natriuretic peptide precursors
#828Inhibitors of caspase-3-mediated cleavage of essential ventricular myosin light chain
#829Methods of antagonizing morphogens
#830Method for immunohistochemical detection of collagen in a tissue sample
#831Modulators of bone homeostasis identified in a high-throughput screen
#832Monoclonal antibody W8B2 and method of use
#833Method and system for the analysis of saliva using a sensor array
#834Compositions and methods for bone formation and remodeling
#835Methods for identifying a chemical compound that directly enhances binding of FKBP12.6 to PKA-phosphorylated type 2 ryanodine receptor (RyR2)
#836Detection of specific nitrated markers
#837Method for monitoring collagen type II degradation in cartilage
#838Gene examination method for judging the onset risk of glaucoma
#839Methods of diagnosing muscle damage
#840Methods for the assay of troponin I and T and complexes of troponin I and T and selection of antibodies for use in immunoassays
#841Method for measuring the amount of betaig-h3 protein and diagnostic kit using the same
#842Methods and compositions to treat cardiovascular disease using 1419, 58765 and 2210
#843Stabilized liquid reference solutions
#844Methods for diagnosis of cardiovascular disease
#845Cell surface tropomyosin as a target of angiogenesis inhibition
#846Fibronectin binding protein compositions and methods of use
#847Methods and compositions relating to HDAC 4 and 5 regulation of cardiac gene expression
#848Methods for assessing muscle protein wasting and therapeutics therefor
#849Methods and compositions for use in diagnosing and characterizing chronic immune disease
#850Superficial zone protein-binding molecules and uses thereof
#851Probes for chondrogenesis
#852Method for the immunohistological detection of fibrogenesis in histological tissue sections using antiboides against C-terminal procollagen alpha1 (III) propeptide
#853Method to diagnose and treat degenerative joint disease
#854Adiponectin-associated protein
#855Assays for evaluating anti-osteoarthritic activity
#856Assay for YKL-40 as a marker for degradation of mammalian connective tissue matrices
#857Clinical assays for thrombospondin fragments in the detection, diagnosis, and evaluation of cancer
#858Methods and means for influencing intracellular communication and intracellular organelle transport
#859Biglycan and related therapeutics and methods of use
#860Assay of isomerised and/or optically inverted proteins and protein fragments
#861Methods and compositions for the assessment of polymer assembly
#862Plasma thermograms for diagnosis and treatment of acute myocardial infarction
#863Methods, systems and devices for assessing wound healing
#864Methods for quantitative assessment of muscle fibers in muscular dystrophy